erythromycin has been researched along with ascorbic acid in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (52.17) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Rawal, BD | 1 |
| Furuya, E | 1 |
| Velizhenko, GG | 1 |
| Kuo, CC; Patton, DL; Wang, SK | 1 |
| Blackhall, MI; McKay, G; Rawal, BD | 1 |
| Bonardi, G; Coppi, G | 1 |
| Bilibin, AF; Ermakova, EIa; Gracheva, N; Rubtsova, LK; Tarasova, AP | 1 |
| Ermolova, OB; Klimova, NE; Zak, AF | 1 |
| Kotua, EN; Moroz, AF | 1 |
| Buniatova, IM; Kotua, EN | 1 |
| Kutskaia, IP; Lazareva, EN; Potravnova, RS; Vakulenko, NA | 1 |
| Trzaski, M | 1 |
| Anderson, R; Eftychis, H; Jooné, G; van Rensburg, AJ; Van Rensburg, CE | 1 |
| Arimura, K; Higuchi, I; Izumo, S; Kawabata, M; Kubota, H; Maruyama, Y; Nakagawa, M; Nakahara, K; Osame, M | 1 |
| Tanzer, JM; Tao, L | 1 |
| Constable, PD; Fürll, M; Körner, I; Sattler, T; Tischer, K; Wittek, T | 1 |
| Droitcourt, C; Dupire, G; Hughes, C; Le Cleach, L | 1 |
2 review(s) available for erythromycin and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antistreptococcal interventions for guttate and chronic plaque psoriasis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ascorbic Acid; Azithromycin; Child; Erythromycin; Humans; Middle Aged; Penicillin V; Psoriasis; Randomized Controlled Trials as Topic; Rifampin; Streptococcal Infections; Tonsillectomy; Vitamins | 2019 |
2 trial(s) available for erythromycin and ascorbic acid
| Article | Year |
|---|---|
[Clinical study of erythromycin ascorbate for parenteral use].
Topics: Adult; Ascorbic Acid; Cholangitis; Clinical Trials as Topic; Erythromycin; Female; Fungi; Humans; Infant; Infections; Male; Meningitis; Meningoencephalitis; Peritonitis; Pneumonia; Staphylococcal Infections; Urine | 1967 |
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antiviral Agents; Ascorbic Acid; Azathioprine; Danazol; Erythromycin; Estrogen Antagonists; Female; Fosfomycin; Glycerol; Human T-lymphotropic virus 1; Humans; Hydrocortisone; Immunoglobulins, Intravenous; Immunosuppressive Agents; Injections, Intramuscular; Injections, Intravenous; Injections, Spinal; Interferon-gamma; Leukapheresis; Male; Methylprednisolone; Middle Aged; Paraparesis, Tropical Spastic; Pentoxifylline; Plasmapheresis; Propiophenones; Respiratory Therapy; Ribonucleosides; Sulfasalazine; Thyrotropin-Releasing Hormone; Vasodilator Agents | 1996 |
19 other study(ies) available for erythromycin and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Bactericidal action of ascorbic acid on Psuedomonas aeruginosa: alteration of cell surface as a possible mechanism.
Topics: Ascorbic Acid; Cell Membrane Permeability; Chloramphenicol; Drug Synergism; Erythromycin; Magnesium; Neomycin; Polymyxins; Pseudomonas aeruginosa; Tetracycline | 1978 |
Removal of interference by erythromycin, phenazopyridine, and methenamine mandelate in the Porter-Silber reaction.
Topics: 17-Hydroxycorticosteroids; Acetazolamide; Adult; Ascorbic Acid; Erythromycin; Humans; Methenamine; Phenazopyridine; Pyridines; Spectrophotometry | 1977 |
[Effect of thiamine, riboflavin and ascorbic acid on tetracycline, erythromycin and levomycetin activity].
Topics: Ascorbic Acid; Bacterial Proteins; Chloramphenicol; Culture Media; Depression, Chemical; Drug Interactions; Erythromycin; Riboflavin; Staphylococcus aureus; Tetracycline; Thiamine | 1975 |
Effects of ascorbic acid on Chlamydia trachomatis infection and on erythromycin treatment in primary cultures of human amniotic cells.
Topics: Amnion; Ascorbic Acid; Cells, Cultured; Chlamydia Infections; Chlamydia trachomatis; Drug Interactions; Erythromycin; Humans | 1992 |
Inhibition of Pseudomonas aeruginosa by ascorbic acid acting singly and in combination with antimicrobials: in-vitro and in-vivo studies.
Topics: Adolescent; Animals; Anti-Bacterial Agents; Ascorbic Acid; Child; Cystic Fibrosis; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Erythromycin; Female; Humans; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfamethoxazole; Trimethoprim | 1974 |
Urease-inhibiting action of some drugs in vitro and in vivo.
Topics: Ammonia; Animals; Anti-Bacterial Agents; Ascorbic Acid; Bacitracin; Chloramphenicol; Chlortetracycline; Demeclocycline; Depression, Chemical; Disease Models, Animal; Enzyme Repression; Erythromycin; Female; Hydroxamic Acids; In Vitro Techniques; Intestines; Kanamycin; Male; Neomycin; Niacinamide; Oxytetracycline; Penicillin G; Rats; Streptomycin; Sulfamethoxypyridazine; Sulfisoxazole; Sulfonamides; Tetracycline; Urease | 1970 |
[Acute toxicity, cytotoxic and local irritating effect of antibiotics of different chemical groups].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Ascorbic Acid; Chick Embryo; Culture Techniques; Erythromycin; Erythromycin Ethylsuccinate; Fibroblasts; Guinea Pigs; Irritants; Kanamycin; Methicillin; Mice; Necrosis; Neomycin; Novobiocin; Oleandomycin; Oxacillin; Penicillin G; Potassium | 1971 |
[Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin].
Topics: Animals; Ascorbic Acid; Drug Resistance, Microbial; Erythromycin; Female; Fetal Death; Pregnancy; Pregnancy Complications, Infectious; Rats; Staphylococcal Infections; Staphylococcus | 1971 |
[Study of transplacental passage of erythromycin ascorbinate].
Topics: Amniotic Fluid; Animals; Ascorbic Acid; Erythromycin; Female; Fetus; Gestational Age; Kidney; Liver; Lung; Maternal-Fetal Exchange; Permeability; Placenta; Pregnancy; Pregnancy, Animal; Rats; Spleen; Time Factors | 1971 |
[Erythromycin-ascorbinate--a drug for parenteral administration].
Topics: Absorption; Animals; Ascorbic Acid; Dogs; Erythromycin; Humans; Injections, Intramuscular; Injections, Intravenous; Kidney; Liver; Lung; Mice; Penicillin Resistance; Solubility; Spleen; Statistics as Topic; Water | 1966 |
[Effect of various drugs in vivo and in vitro on the results of the most frequently performed enzymatic determinations in a clinical laboratory].
Topics: Alanine Transaminase; Alkaline Phosphatase; Aminopyrine; Amylases; Antipyrine; Ascorbic Acid; Aspartate Aminotransferases; Chlorpropamide; Clinical Enzyme Tests; Diazepam; Drug Combinations; Enzyme Activation; Enzyme Inhibitors; Erythromycin; Female; Humans; In Vitro Techniques; L-Lactate Dehydrogenase; Male; Pemoline; Phenylbutazone; Poland; Salicylates | 1980 |
Further studies on erythromycin effects on cellular immune functions in vitro and in vivo. Enhancement of neutrophil motility by erythromycin combined with ascorbate or thiamine.
Topics: Ascorbic Acid; Cell Movement; Erythromycin; Humans; Immunity, Cellular; Iodine; Lymphocyte Activation; Neutrophils; Peroxidases; Thiamine | 1982 |
Novel sucrose-dependent adhesion co-factors in Streptococcus mutans.
Topics: Analysis of Variance; Animals; Anti-Bacterial Agents; Ascorbic Acid; ATP-Binding Cassette Transporters; Bacterial Adhesion; Bacterial Proteins; Chromosome Mapping; Clone Cells; Drug Resistance, Bacterial; Erythromycin; Glucans; Glucosyltransferases; Glycerolphosphate Dehydrogenase; Membrane Transport Proteins; Mutation; Operon; Phenotype; Polysaccharides, Bacterial; Rats; Ribulosephosphates; Statistics as Topic; Streptococcus mutans; Sucrose; Transformation, Bacterial | 2002 |
Effect of preoperative erythromycin or dexamethasone/vitamin C on postoperative abomasal emptying rate in dairy cows undergoing surgical correction of abomasal volvulus.
Topics: Abomasum; Animals; Ascorbic Acid; Cattle; Cattle Diseases; Dexamethasone; Erythromycin; Female; Gastric Emptying; Postoperative Care; Preoperative Care; Prospective Studies; Random Allocation; Stomach Volvulus; Treatment Outcome | 2008 |